TOT BIOPHARM International Company Limited (1875.HK)

HKD 1.65

(0.0%)

Long Term Debt Summary of TOT BIOPHARM International Company Limited

  • TOT BIOPHARM International Company Limited's latest annual long term debt in 2023 was 302.87 Million CNY , up 42.55% from previous year.
  • TOT BIOPHARM International Company Limited's latest quarterly long term debt in 2024 Q2 was 314.91 Million CNY , down 0.0% from previous quarter.
  • TOT BIOPHARM International Company Limited reported annual long term debt of 212.47 Million CNY in 2022, up 248.83% from previous year.
  • TOT BIOPHARM International Company Limited reported annual long term debt of 60.91 Million CNY in 2021, up 901.33% from previous year.
  • TOT BIOPHARM International Company Limited reported quarterly long term debt of 310.03 Million CNY for 2023 Q2, down 0.0% from previous quarter.
  • TOT BIOPHARM International Company Limited reported quarterly long term debt of 302.87 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of TOT BIOPHARM International Company Limited (2023 - 2017)

Historical Annual Long Term Debt of TOT BIOPHARM International Company Limited (2023 - 2017)

Year Long Term Debt Long Term Debt Growth
2023 302.87 Million CNY 42.55%
2022 212.47 Million CNY 248.83%
2021 60.91 Million CNY 901.33%
2020 6.08 Million CNY -50.54%
2019 12.29 Million CNY -3.99%
2018 12.81 Million CNY -95.17%
2017 264.95 Million CNY 0.0%

Peer Long Term Debt Comparison of TOT BIOPHARM International Company Limited

Name Long Term Debt Long Term Debt Difference
Uni-Bio Science Group Limited 30.61 Million HKD -889.413%
CK Life Sciences Int'l., (Holdings) Inc. 4.27 Billion HKD 92.912%